|
November 3, 2012: Dr. Elizabeth A. Magnuson and Dr. C. Michael Gibson discuss: Cost-Effectiveness of PCI with Drug Eluting Stents versus B |
Dr. Elizabeth A. Magnuson and Dr. C. Michael Gibson discuss: Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial
FREEDOM was supported by U01 grants #01HL071988 and #01HL092989 from the National Heart Lung and Blood Institute Other support - Drug eluting stents were provided by Cordis, Johnson and Johnson and Boston Scientific - Abciximab and an unrestricted research grant were provided by Eli Lilly and Company - Clopidogrel was provided by Sanofi Aventis and Bristol-Myers Squibb
[ Download video ] |
|
No comments have been submitted
|